Aims: Glucose 6-phosphate dehydrogenase (G6PD) is essential for maintenance of nicotinamide dinucleotide hydrogen phosphate (NADPH) levels and redox homeostasis. A number of drugs, such as antimalarial drugs, act to induce reactive oxygen species and hemolytic crisis in G6PD-deficient patients. We used diamide (DIA) to mimic drug-induced oxidative stress and studied how these drugs affect cellular metabolism using a metabolomic approach.
Results: There are a few differences in metabolome between red blood cells (RBCs) from normal and G6PD-deficient individuals. DIA causes modest changes in normal RBC metabolism. In contrast, there are significant changes in various biochemical pathways, namely glutathione (GSH) metabolism, purine metabolism, and glycolysis, in G6PD-deficient cells. GSH depletion is concomitant with a shift in energy metabolism. Adenosine monophosphate (AMP) and adenosine diphosphate (ADP) accumulation activates AMP protein kinase (AMPK) and increases entry of glucose into glycolysis. However, inhibition of pyruvate kinase (PK) reduces the efficacy of energy production. Metabolic changes and protein oxidation occurs to a greater extent in G6PD-deficient RBCs than in normal cells, leading to severe irreversible loss of deformability of the former.
Innovation And Conclusion: Normal and G6PD-deficient RBCs differ in their responses to oxidants. Normal cells have adequate NADPH regeneration for maintenance of GSH pool. In contrast, G6PD-deficient cells are unable to regenerate enough NADPH under a stressful situation, and switch to biosynthetic pathway for GSH supply. Rapid GSH exhaustion causes energy crisis and futile AMPK activation. Our findings suggest that drug-induced oxidative stress differentially affects metabolism and metabolite signaling in normal and G6PD-deficient cells. It also provides an insight into the pathophysiology of acute hemolytic anemia in G6PD-deficient patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361223 | PMC |
| http://dx.doi.org/10.1089/ars.2014.6142 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Rate of glucose-6-phosphate dehydrogenase deficiency in neonatal indirect hyperbilirubinemia at a private tertiary centre.
Saudi Med J
October 2024
From the Neonatal Intensive Care Unit (Alhiwaishil, Alghareeb, Alkhars, Abdalla), Almoosa Specialist Hospital, from the Neonatal Intensive Care Unit (Almohsen), Ministry of Health, Al-Ahsa, Kingdom of Saudi Arabia, and from the Department of Nursing and Health Sciences (Al Mutair), Monash University, Melbourne, Australia.
Objectives: To investigate the rate of hospitalized neonates with glucose-6-phosphate dehydrogenase (G6PD) deficiency presented with indirect hyperbilirubinemia at a private tertiary center in Al-Ahsa, Saudi Arabia, over 4 years and to compare the characteristics of G6PD-deficient and normal neonates admitted for indirect hyperbilirubinemia.
Methods: The retrospective case control study was carried out at Almoosa Specialist Hospital, Al-Ahsa, Saudi Arabia. Data were collected from Yassasi Medical System from 2018-2021 and finalized in 2024.
Glucose-6-phosphate dehydrogenase deficiency detection using fluorocytometric assay: Evaluation after 1 year of clinical implementation.
Cytometry B Clin Cytom
October 2024
Department of Biological Hematology, Rouen University Hospital, Rouen, France.
Article Synopsis
- - G6PD deficiency is a genetic condition that affects red blood cells, making them more vulnerable to oxidative stress, potentially leading to hemolytic anemia, especially after certain drug exposures or infections.
- - A study evaluated flow cytometry as an alternative diagnostic tool for G6PD deficiency in 514 samples, finding it to be more effective than traditional spectrophotometry, particularly in identifying cases in heterozygous females.
- - While flow cytometry demonstrated high sensitivity and specificity, it also had some limitations, such as false negatives in patients with sickle cell disease, indicating the need for careful interpretation of results in those with other blood disorders.
Analytical and operational considerations of measuring glucose 6-phosphate dehydrogenase (G6PD) activity using a fully automated assay.
Am J Clin Pathol
August 2024
Pathology and Laboratory Medicine, Cleveland Clinic Foundation, Cleveland, OH, US.
Article Synopsis
- A study tested a new automated method to measure G6PD levels in blood, which helps check for certain health issues.
- They found the method worked well and was consistent over time, with good results in many patients.
- The testing showed that some people, especially males, were G6PD deficient, which means their levels were low and may need attention.
Comparative evaluation of oxidative and biochemical parameters of red cell concentrates (RCCs) prepared from G6PD deficient donors and healthy donors during RCC storage.
Transfus Clin Biol
November 2024
Department of Biochemistry, Faculty of Biological Science, North Tehran Branch, Islamic Azad University, Tehran, Iran.
Introduction: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common inherited enzyme disorder in red blood cell (RBC). Due to the importance of G6PD enzyme as an antioxidant in RBC, we tried to investigate the oxidative damage in red cell concentrates (RCCs) prepared from donors with G6PD enzyme deficiency in comparison with healthy donors.
Material Method: This cross-sectional study was conducted on 20 male donors.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!